Integral Health Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Integral Health Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.1M	Sell	550,000 -50,000	-8%	-$4.52M	2.41%	10
2026 Q1	$52.2M	Buy	600,000 +125,000	+26%	+$12.2M	2.5%	11
2025 Q4	$50.8M	Buy	475,000 +255,000	+116%	+$27M	2.52%	8
2025 Q3	$22.2M	Buy	220,000 +100,000	+83%	+$9.28M	1.5%	19
2025 Q2	$7.58M	Buy	+120,000	New	+$7.35M	0.69%	41
2025 Q1	–	Sell	-150,000	Closed	-$8.4M	–	103
2024 Q4	$8.4M	Buy	+150,000	New	+$8.29M	0.72%	48

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Integral Health Asset Management's RYTM Position: Q2 2026 in Review

Integral Health Asset Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 8.3% in Q2 2026, selling an estimated $4.52M and leaving 550,000 shares worth $61.1M. The position accounts for 2.41% of the portfolio, ranked #10.

Integral Health Asset Management first reported a position in RYTM in Q4 2024 and has held it in 6 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Integral Health Asset Management held 550,000 shares of Rhythm Pharmaceuticals worth $61.1M as of Q2 2026.
Integral Health Asset Management sold 50,000 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.52M.
Rhythm Pharmaceuticals made up 2.41% of Integral Health Asset Management's portfolio in Q2 2026, its #10 holding.
Integral Health Asset Management first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.